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For the purpose of environmental biomonitoring analytical procedures for the sensitive and efficient speciation
of the arsenic species As(III), As(V), monomethylarsonic acid (MMA), dimethylarsinic acid (DMA),
trimethylarsine oxide (TMAO), tetramethylarsonium ion (Tetra), arsenobetaine and arsenocholine have been
optimized. The influence of different nebulizers, in particular cross flow and hydraulic high pressure, on the
analytical performance and quality parameters such as limit of detection and reproducibility was investigated.
LODs in the range of a few pg or even below were achieved. The HPLC-ICP-MS procedures were validated by
using reference materials.
Introduction
Arsenic is a widely distributed element in environmental
systems and occurs in a large number of various species which
differ not only in their physicochemical behaviour but also in
toxicity, bioavailibility and biotransformation. In order to
distinguish between the single species high performance liquid
chromatography (HPLC) is a frequently used method for the
separation, focused on the inorganic ions and the organic
compounds monomethylarsonic acid (MMA), dimethylarsinic
acid (DMA), arsenobetaine (AB), arsenocholine (AC), tetra-
methylarsonium ion (Tetra) and trimethylarsine oxide
(TMAO). Applications of ion-exchange1–6 and ion-pairing
reversed-phase chromatography2,7,8 have been reported, in
which the latter is described to be more susceptible to matrix
interferences.9,10
In contrast to urine samples where AB, DMA, MMA and
the inorganic ions are the most frequently occurring arsenic
compounds8,11–13 the species pattern in environmental samples
is much more complex. The more information is obtained
about the diversity of arsenic species in environmental samples
the better the separation is supposed to be. With some
exceptions using tandem MS spectrometry14,15 the identifica-
tion of the arsenic compounds is mostly performed by
comparing the retention times of standards with those of the
peaks in the investigated samples. Therefore, a poor resolution
can induce that unknown species with a slightly different
retention time to be easily covered by other species. Also,
compounds which elute with no retention can merge with other
unknown species which elute with the dead volume as well. So
it is necessary to get a good baseline separation of all species in
an acceptable time. To our knowledge there is no method
described in the literature where all eight arsenic species are
baseline separated and no species elutes with the void volume in
one chromatographic run. Therefore, the development of an
ideal separation method of the eight arsenic species is still a
major challenge.
The combination of HPLC with inductively coupled plasma
mass spectrometry (ICP-MS) for detection is a powerful
coupling technique for arsenic speciation.10,13,16–21 The com-
monly used interfaces for arsenic speciation by using HPLC
with ICP-MS detection are cross flow and the Meinhard-type
nebulizer. Recently, B’Hymer et al.22 have reported a
comparison of the oscillating capillary nebulizer, concentric
nebulizer and Meinhard-type high-efficiency nebulizer with
different spray chambers. However, the total arsenic concen-
trations in environmental samples are in the lower ng g21 level.
Considering the dilution of the sample during the extraction
and the separation on the column into the single species, very
low concentrations of arsenic have to be determined. Although
the sensitivity of ICP-MS is very good, the detection power
obtained by these nebulizers is not sufficient because of their
moderate nebulization and transport efficiency. Only a few
papers on arsenic speciation have reported concerning
improvement of the sensitivity by applying more efficient
nebulizers like the ultrasonic nebulizer (USN)23 or the
hydraulic high pressure nebulizer (HHPN).24
The purpose of the present work was to develop a powerful
separation and detection method that allows the investigation
of biological samples as part of systematic environmental
monitoring. Therefore, this paper discusses the separation of
eight arsenic compounds by anion-exchange and cation-
exchange chromatography coupled to ICP-MS, which was
equipped with either a cross flow nebulizer, USN or HHPN. A
systematic comparison of the different nebulizers on the
chromatographic separation and on the behaviour of the
arsenic species was performed.
Experimental
Instrumentation
The chromatographic system consisted of a Merck L-6220
Intelligent Pump (PEEK model; Merck, Darmstadt, Ger-
many), a Rheodyne Model 9125 six-port injection valve fitted
with a 20 ml sample loop and a Mistral column thermostat
(Spark Holland Instruments, Emmen, Netherlands). Two
anion-exchange columns have been used: a PRP-X100
(25064.1 mm id; Hamilton, Reno, USA) and an Ion-120
(12564.6 mm id; Interaction Chromatography, San Jose, CA,
USA). Both are based on polystyrene–divinylbenzene resins
and consequently these columns are stable in a pH range from 1
to 13. Cation-exchange chromatography was performed on a
Nucleosil 5SA (25064.0 mm id; Machery-Nagel, Germany).
All columns were used with the appropriate guard columns.
Different nebulizer systems were connected to the outlet of
the HPLC. A cross flow nebulizer provided with a GemTip
nozzle and a Scott-type spray chamber, a USN U-6000 ATz
(Cetac Technologies Inc., Omaha, Nebraska, USA) and a
HHPN, which was constructed ourselves in cooperation with
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the Institute of Spectroscopy and Spectrochemistry (Dort-
mund, Germany). Using USN and HHPN the aerosol was
dried by desolvation (heating to 100 ‡C, cooling to 0 ‡C).
Therefore, the spray chamber of the HHPN was connected to
the desolvation unit of an USN-5000 AT (Cetac Technologies
Inc.).
The detection was performed with a Perkin Elmer Elan 5000
ICP-MS (Perkin Elmer Sciex, Thornhill, Ontario, Canada).
The instrument was first optimized off-line for arsenic with an
aqueous As(V) standard each time. The instrumental para-
meters for the ICP-MS coupled to HPLC are given in Table 1.
The ion intensity at m/z 77 was monitored if an interference of
40Ar35Cl at m/z 75 was suspected. However, the interference
was not observed in any instance.
Reagents and standards
For the preparation of reagents and standards Milli-Q
(Millipore, Milford, MA, USA) water of 18.2 MV cm was
used. Except for NH3.aq and NH4H2PO4, both Suprapure
quality, all chemicals for preparing the mobile phases were of
pro analysi quality.
A commercially available arsenate solution (1000 mg l21,
As2O5 in H2O) (Titrisol, Merck) was used. The 1000 ppm
As(III) standard was prepared by dissolution of 0.264 g arsenic
trioxide (Aldrich, Milwaukee, WI, USA) in 200 ml 0.2% NaOH
and used for about 2 months. Dimethylarsinic acid (0.286 g)
(Fluka, Buchs, Switzerland) was dissolved in 100 ml water
to give a 1000 mg l21 solution. Stock standard solutions
(1000 mg l21 As) of AB, AC, Tetra, TMAO and MMA were
kindly donated by W. Goessler (Institute for Analytical
Chemistry, Karl-Franzens-University Graz, Austria).
The concentrations of the standards were checked by
determination of the total arsenic by ICP-MS after acid
digestion. All solutions were stored refrigerated and in the dark
to prevent decomposition or oxidation. The final standard
mixtures were prepared daily from a 20 ppm standard solution
except for As(III) which was prepared from a 1000 ppm solution
each time.
Certified reference materials used in the present study were
DORM-2 (Dogfish Muscle) from the National Research
Council of Canada (Ottawa, Canada) and CRM 627 (Tuna
Fish) from BCR (IRMM Geel, Belgium).
Chromatographic conditions
The chromatographic conditions are presented in Table 2. The
mobile phases were prepared by dissolving or dilution of the
appropriate amount of NH4HCO3, NH4H2PO4 or pyridine in
Milli-Q water, adding 2% (v/v) methanol for increasing the
sensitivity of the ICP-MS signals and afterwards adjusting the
pH according to the values mentioned in Table 2. All mobile
phases were deaerated with helium before use.
For quantification of the arsenic species standard addition
was used. Calculation was performed with the Perkin Elmer
(Ueberlingen, Germany) software Chromafile MS plus 1.0. The
quantification of the chromatographic peaks was based on the
peak area.
Extraction procedure
The certified reference materials were extracted by a procedure
slightly modified in comparison to a method of Goessler et al.24
Approximately 0.2 g of the freeze-dried sample was weighed
into a 16 ml polyethylene centrifuge tube and 10 ml of
methanol–water (9z1 v/v) were added. The tubes were
shaken overnight. Afterwards the extracts were centrifuged
at 17 000 rpm for 15 min and the clear supernatants were
transfered into round bottomed flasks. The extraction residues
were washed three times with methanol–water (9z1 v/v). The
extracts were combined and the methanol was evaporated on a
rotary evaporator at temperatures not above 35 ‡C. Each
sample was filled up to 10 ml with water. Before injection the
sample was filtered through a 0.22 mm cellulose filter (Sartorius,
Table 1 Operating conditions for ICP-MS
ICP-MS spectrometer Perkin Elmer Elan 5000
Rf power 1300 W
Plasma gas 15.0 ml min21
Auxiliary gas 0.81 ml min21
Nebulizer gasa 1.02 ml min21
Cones Ni and Pt
Dwell time 1100 ms
Sweeps/reading 1
Reading/replicate 1
Analytical mass m/z 75 and m/z 77
aOptimized each day.
Table 2 Operating conditions for the chromatographic system
Anion-exchange chromatography—
Column Parameters
Hamilton PRP-X100 Mobile phase A: 0.25 mmol l21 NH4H2PO4; 2% (v/v) MeOH; pH 9.0
a
Mobile phase B: 20 mmol l21 NH4H2PO4; 2% (v/v) MeOH; pH 8.8
a
Gradient program: 100% A for 5 min, decreasing to 100% B in 0.1 min and maintaining for 10 min. Regeneration
for 10 min with 100% A
Ion-120 Mobile phase A: 5 mmol l21 NH4HCO3; 2% (v/v) MeOH; pH 10.3
a
Mobile phase B: 50 mmol l21 NH4HCO3; 2% (v/v) MeOH; pH 10.3
a
Gradient program: 100% A for 1 min, decreasing to 100% B in 3 min and maintaining for 6 min. Regeneration for
10 min with 100% A




Nucleosil 5SA Isocratic mode: 30 mmol l21 pyridine; 2% (v/v) MeOH; pH 3.0 (adjusted with HCOOH)
Other parameters—
Temperature 25 ‡C
Injection volume 20 ml
Flow rate 1 ml min21
apH adjusted with NH3.aq.
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Goettingen, Germany) and diluted with water to an appro-
priate concentration.
Results and discussion
The arsenic species As(III), As(V), DMA, MMA, AB, AC, Tetra
and TMAO occur as neutral, positively or negatively charged
compounds depending on the pH so that ion exchange
chromatography appears to be a suitable method for separa-
tion. To obtain a good resolution of these eight arsenic species
in an acceptable time concerning the facts mentioned above
anion-exchange and cation-exchange chromatography was
used.
Separation of arsenic compounds by anion-exchange
chromatography
The four arsenic species As(III), As(V), DMA and MMA were
separated using anion-exchange chromatography. For the
retention of arsenite with a pKa value of 9.2 it is necessary to
work in a basic environment otherwise As(III) will elute with the
void volume. Because silica-based columns can only be applied
in a pH range up to 7 polystyrene–divinylbenzene-based anion-
exchange columns were used.
For optimization of the chromatographic parameters the
influence of pH, composition and concentration of the mobile
phase and temperature was studied for two different anion-
exchange columns. Cross flow nebulizer gradient programs
were found to provide the best separation where all species
were baseline resolved and none of the anionic compounds
eluted with the void volume. Therefore, a gradient programme
with NH4H2PO4 buffer as mobile phase using a PRP-X100
column and a NH4HCO3 buffer for the Ion-120 was used. The
detailed conditions are shown in Table 2. Corresponding
chromatograms are presented in Figs. 1 and 2. The separation
behaviour was similar on both columns: the arsenic species AB,
AC, Tetra and TMAO which are cations at basic pH eluted
with the void volume. MMA and As(V) appeared in the same
order. However, As(III) and DMA showed reversed retention
behaviour.
On the Ion-120 As(III) eluted later than DMA. That is
surprising, because at the pH of 10.3 both species have an
apparent charge of 21 and it would be more likely that the
larger hydrophobic interactions of DMA to the stationary
phase cause a longer retention time. Decreasing the pH resulted
in an approach of both peaks and at pH between 9.5 and 9 they
merge completely.
On the column RPR-X100 the pH used was lower. A higher
pH would cause an overlapping of As(III) and DMA so that the
best separation was achieved at pH 8.8.
After optimization of the separation using the cross flow
nebulizer the method was applied to a USN for increasing the
detection power. By measuring the baseline during the gradient
program an increase of the baseline on both columns was
observed when mobile phase B with the higher buffer
concentration was started. Also a peak at the same retention
time of As(V) arose although no injection was carried out
(Fig. 3). The effects varied depending on the regeneration time:
the peak increased seriously if the time between the two
injections was longer, especially after conditioning of the
column. It was supposed that an impurity of arsenic may be
responsible for this phenomenon. The total arsenic content in
Fig. 1 HPLC-ICP-MS chromatogram for the separation of As(III),
As(V), MMA, DMA and AB (in distilled water, each species 50 mg
As l21) using cross flow nebulizer, Ion-120 anion-exchange column and
NH4HCO3 gradient (for details of conditions see Table 2).
Fig. 2 HPLC-ICP-MS chromatogram for the separation of As(III),
As(V), MMA, DMA and AB (in distilled water, each species 50 mg
As l21) using cross flow nebulizer, Hamilton PRP-X100 anion-
exchange column and NH4H2PO4 gradient (for details of conditions
see Table 2).
Fig. 3 Baseline running the NH4HCO3 gradient programme on an
ION-120 anion-exchange column using USN for nebulisation without
any injection.
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the NH4HCO3 was determined and resulted in a concentration
of 2.5 ng g21 As. It is very likely that this arsenic impurity in
the form of As(V) was accumulated on the column during the
regeneration and conditioning steps, respectively. In both steps
the lower buffer concentration of the gradient programme was
used where no elution of As(V) takes place. Running the
gradient programme the accumulated arsenic could be
mobilized when mobile phase B with the higher buffer
concentration was started and a peak appeared after almost
the same retention time as when As(V) was injected. Therefore,
different NH4HCO3 salts were tested but all of them showed
similar behaviour. Also experiments with the HHPN produced
the same results. There was no further testing performed with
other NH4H2PO4 salts because the use of this mobile phase
seems to cause damage to the sampler cone, possibly because of
the relatively high efficiency of the HHPN (15%) compared to
the cross flow nebulizer and hence to a higher transfer of
phosphate into the plasma.
The effect of an arsenic impurity in the mobile phase during a
gradient programme was not observed by using a cross flow
nebulizer, probably because of the lower sensitivity of this
nebulizer. But this effect was also observed on another column
with another gradient programme and a Meinhard-type
nebulizer.
Because mobile phases slightly contaminated with arsenic
did not allow the running of a gradient programme with use of
the more efficient nebulizers USN and HHPN, further
investigations were performed with an isocratic mode to
separate the anionic arsenic species.
Based on an approach proposed by Hansen et al.18 the
separation of the four anionic arsenic species in an isocratic
mode on the Ion-120 anion-exchange column was optimized
for the system used in this study. Compared to the method of
Hansen it was found that a lower concentration of the
NH4HCO3 buffer and a lower temperature was necessary to
obtain a good separation of As(V), As(III), MMA and
DMA. A chromatogram using the HHPN is presented in
Fig. 4. Similar to the separation by the gradient mode
mentioned above, AB, AC, Tetra and TMAO eluted with
the void volume.
Separation of arsenic compounds by cation-exchange
chromatography
For the separation of AB, AC, Tetra and TMAO a Nucleosil
5SA cation-exchange column was used. Approaches using
pyridine as mobile phase under isocratic conditions have
already been described in the literature.18,19 First the
optimization of pH, temperature and concentration of pyridine
was performed with a cross flow nebulizer. The following
transfer to USN and HHPN, respectively, was achieved
without any problem. A chromatogram is presented in Fig. 5
using HHPN for nebulization. It is shown that As(V), DMA,
AB, TMAO, AC and Tetra are very well baseline separated.
The retention of DMA on a cation-exchange column may be an
effect of the formation of (CH3)2As
z(OH).18 The species
MMA and As(III) elute between As(V) and DMA. If a real
sample contains all four anionic species in similar amounts the
separation will be successful for qualitative analysis but for
quantitative analysis it will be not sufficient. As(V) elutes with
the void volume and therefore it is likely that it will appear
together with unknown negatively or uncharged arsenic
species. Therefore, As(V) is better quantified by anion-exchange
chromatography.
Influence of nebulizer and chromatographic parameters on the
signal intensity
Measurements of the eight arsenic species in HNO3 solutions
by ICP-MS with the cross flow nebulizer without any
chromatographic system provided the same intensity for each
compound. However, the HPLC-ICP-MS chromatograms
presented in Figs. 4 and 5 exhibit that the signal intensities
of the eight arsenic species are different. Especially As(III) in the
anion-exchange chromatogram and DMA and TMAO in the
cation-exchange chromatogram show significant lower inten-
sities compared to the other species. The signal depression
might be an effect of the column and/or of the nebulizer system.
Therefore, investigations were performed to study the signal
intensities of the arsenic species with and without the column in
combination with two different kinds of nebulizers. The species
were separated on the appropriate ion-exchange column which
was connected to HHPN and cross flow nebulizer, respectively.
Thereafter, each species was injected separately without the
Fig. 4 HPLC-ICP-MS chromatogram for the separation of As(III),
As(V), MMA, DMA and AB (in distilled water, each species 2 mg
As l21) using HHPN and an ION-120 anion-exchange column (mobile
phase 30 mM NH4HCO3, pH 10.0, injection volume 20 ml, flow rate
1.0 ml min21, 25 ‡C).
Fig. 5 HPLC-ICP-MS chromatogram for the separation of DMA,
As(V) AB, AC, Tetra and TMAO (in distilled water, each species 2 mg
As l21) using HHPN, Nucleosil 5SA cation-exchange column (mobile
phase 30 mM pyridine, pH 3.0, injection volume 20 ml, flow rate
1.0 ml min21, 25 ‡C).
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column, just running the same mobile phase which was used for
the relevant separation. The results are summarized in Table 3.
The values represent relative intensities related to the intensity
of As(V) which was normalized to 1 for each run. For this
experiment the total arsenic concentrations of the standards
were checked by ICP-MS after acid digestion.
Table 3 shows that the intensities obtained for DMA and
TMAO using the separation with pyridine as mobile phase on
the cation-exchange column and HHPN for nebulization
(Fig. 4) were just 80 and 67%, respectively, compared to the
As(V) signal. But in the case of the cross flow nebulizer the
intensities of the six investigated compounds were almost equal
(99–108%). On the other hand the relative intensities for DMA
and TMAO with and without the Nucleosil column are similar
in each case (DMA: 0.80 and 0.81; TMAO: 0.67 and 0.64). The
same behaviour is observed if a cross flow nebulizer is used
(DMA: 1.01 and 0.99; TMAO: 1.00 and 1.02). This indicates
that the lower sensitivity of DMA and TMAO is not an effect
of the column but of the nebulizer. A loss of these species in the
desolvation step of the HHPN would be a possible explanation.
To investigate the influence of the desolvation the intensities of
the species were determined with regard to dependence on the
heating temperature in this step (Fig. 6). A temperature increase
enhances the vaporization of eluent in the aerosol which will
cause a higher sensitivity. As expected an increase of the signal
intensities at higher temperatures could be observed in the case of
the species As(V), DMA, AB, AC and Tetra. However, TMAO
showed a reverse behaviour: the intensity of this species decreased
by about 40% after changing the temperature from 100 ‡C to
160 ‡C. The different behaviour of TMAO indicates that there is
another effect during the desolvation of this particular species,
which eventually causes the lower intensity of TMAO in the
cation-exchange chromatogram.
Concerning the anion-exchange chromatography on the Ion-
120 (Fig. 4) As(III) exhibited a much lower signal intensity than
the other species (33% in comparison to the As(V) signal).
Table 3 shows an increase of the intensity if the column was
removed and also if the HHPN was replaced by a cross flow
nebulizer. Therefore, the lower intensity of As(III) seems to be
an effect of both the column and the nebulizer.
Corresponding investigations regarding the dependence of
the intensity on the heating temperature in the desolvation step
were also performed for the species separated by anion-
exchange chromatography (Fig. 7). The expected increase of
the intensity with higher temperature is obtained in the case of
As(V), MMA and AB, with the strongest effect on As(V). The
intensities of DMA and As(III) are almost similar at each
temperature.
These experiments demonstrated that the eight arsenic
species show a different behaviour in the desolvation step
using HHPN. Therefore, it can be assumed that the HHPN
nebulizer system is a reason for the different intensities of the
species in the HPLC-ICP-MS chromatograms. But in the case
of As(III) other effects besides nebulization seem also to
contribute to the lower intensity of this species.
Detection limits and precision of the methods
The detection limits were determined by using the calibration
curve method (cdl~4sxc/m; m~slope of a calibration curve
close to the detection limit, sxc~standard deviation as a
function of the deviations of the measurements of each
concentration).{ In comparison to the 3s method the
Fig. 6 Arsenic signal as peak area of As(V), DMA, AB, AC, Tetra and
TMAO obtained as a function of the heating temperature in the
desolvation unit of the HHPN (intensity at 100 ‡C was set to 100%).
Mean value (three repetitions, RSD 1–4%), separation conditions as for
Fig. 5.
Table 3 Influence of nebulizer and chromatographic parameters on the signal intensity (peak area) of the arsenic species (values are the relative
intensities related to As(V) which was normalized to 1 for each run)
Mobile phase Nebulizer Column As(V) DMA AB TMAO AC Tetra As(III) MMA
Pyridine HHPN Nucleosil 1 0.80 1.05 0.67 0.96 1.00
No 1 0.81 1.03 0.64 0.99 0.98
Cross flow Nucleosil 1 1.01 1.05 1.00 0.99 1.08
No 1 0.99 1.02 1.02 0.99 1.05
NH4HCO3 HHPN ION-120 1 0.95 0.94 0.33 0.87
No 1 0.95 0.96 0.66 0.87
Cross flow ION-120 1 0.92 0.96 0.68 0.88
No 1 0.98 1.05 0.99 0.91
Fig. 7 Arsenic signal as peak area of DMA, MMA, AB, As(III) and
As(V) obtained as a function of the heating temperature in the
desolvation unit of the HHPN (intensity at 100 ‡C was set to 100%).











where i~Concentration i, n~total number of measurements, j~repe-
titive measurements at one concentration i.
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calibration curve method considers not only the sensitivity but
also the reproducibility of single species determinations.
Tables 4 and 5 show the detection limits and reproducibilities
for the cation-exchange and anion-exchange chromatography,
respectively.
In the case of cation-exchange chromatography using
HHPN as nebulizer the detection limits for As(V), AB, AC
and Tetra are 10 to 20 times higher than using the cross flow
nebulizer. However, the detection limits for TMAO improved
by just a factor of four. This corresponds to the effect of
TMAO using HHPN which has been discussed above.
Surprisingly the reproducibility of TMAO determination
with HHPN is comparable to the other compounds which
resulted in the relatively low detection limit despite the lower
intensity of this species in the chromatogram.
Regarding the determination of the anionic species the
detection limits for using the cross flow nebulizer (Table 5) are
in the same range as the cationic species in Table 4. However,
the detection limits are higher for the anionic species than for
the cationic species using HHPN. It is likely that the mobile
phase NH4HCO3 used in the anion-exchange chromatography
changed the condition of the plasma of the ICP-MS because of
the higher salt concentration. This effect would be more
pronounced with the HHPN because of its higher efficiency.
Beside an influence on the plasma conditions the higher salt
concentration could also influence the nebulization and
desolvation.
Arsenic speciation in certified reference materials
For testing the accuracy of the methods in real samples two
reference materials were investigated. Tuna fish from BCR was
to our knowledge the first reference material which has been
certified for arsenic species. For DORM-2 only the comparison
to other published results can be used to check the method. The
quantification of DMA was performed using both cation- and
anion-exchange chromatography. The concentrations obtained
with both methods were consistent so that the results were
combined. AB and Tetra were determined by cation-exchange
chromatography. In all cases HHPN was used as nebulizer.
The concentrations found for AB (3.81¡0.05 mg g21 As) and
DMA (0.145¡0.006 mg g21 As) are in very good agreement
with the certified concentrations in the CRM 627 (AB:
3.90¡0.24 mg g21 As, DMA: 0.15¡0.02 mg g21 As).
The concentration of AB in DORM-2 (Table 6) varies in a
range of 16.0 to 17.2 mg g21 As. Related to the total arsenic
concentration of DORM-2 (18.01.1 mg g21 As) the percentage
of AB is between 88 and 95%. By considering the low
concentration of DMA and Tetra the results are comparable,
even if we found a DMA concentration which is by a factor of
two higher than published by Goessler et al.25
Conclusions
The optimized analytical procedures offer sufficient detection
power and reproducibility for the investigation of species
patterns of As(III), As(V), MMA, DMA, TMAO, Tetra, AB and
AC in bioindicators from different ecosystems. The anion-
exchange and cation-exchange chromatography is not suited
for the analysis of arsenosugars which occur at low trophic
levels in the marine environment. For that purpose other
chromatographic approaches have to be used.
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